Ben Ke, Wen Shen, Jianling Song, & Xiangdong Fang. (2023). MG53: A potential therapeutic target for kidney disease. Wiley.
Chicago Style (17th ed.) CitationBen Ke, Wen Shen, Jianling Song, and Xiangdong Fang. MG53: A Potential Therapeutic Target for Kidney Disease. Wiley, 2023.
MLA (9th ed.) CitationBen Ke, et al. MG53: A Potential Therapeutic Target for Kidney Disease. Wiley, 2023.
Warning: These citations may not always be 100% accurate.